Yahoo Web Search

    • Why AstraZeneca Stock Is Trading Higher Today

      Benzinga via Yahoo Finance· 4 days ago

      "We are encouraged by the PROpel results and the clinical benefit LYNPARZAin combination with abiraterone demonstrated versus abiraterone alone as a 1st-line treatment option ...

    • Analyst Report: Myriad Genetics, Inc.

      Analyst Report: Myriad Genetics, Inc.

      Morningstar Research via Yahoo Finance· 11 hours ago

      The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

    • Vail Resorts, Progress Software rise; Nike, Nvidia fall

      Associated Press via Yahoo News· 4 days ago

      The business software maker's fiscal third-quarter financial results beat Wall Street forecasts. Merck & Co., up 56 cents to $73.61. The drug developer reported encouraging results from a study ...